Your browser doesn't support javascript.
loading
Estimating the distribution of a novel clinical biomarker (FGF-23) in the US population using findings from a regional research registry.
Johnston, Joseph A; Nelson, David R; Zhang, Limin; Curtis, Sarah E; Voelker, James R; Wetterau, John R.
Afiliação
  • Johnston JA; Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Indianapolis, Indiana, United States of America.
  • Nelson DR; Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Indianapolis, Indiana, United States of America.
  • Zhang L; Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Indianapolis, Indiana, United States of America.
  • Curtis SE; Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Indianapolis, Indiana, United States of America.
  • Voelker JR; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America.
  • Wetterau JR; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America.
PLoS One ; 14(6): e0218435, 2019.
Article em En | MEDLINE | ID: mdl-31246994
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Fatores de Crescimento de Fibroblastos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Fatores de Crescimento de Fibroblastos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article